Gene · 994
Papers2,079
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
281 to 300 of 2,079
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Transcriptional Regulation of ING5 and its Suppressive Effects on Gastric Cancer. | Front Oncol | 2022 | 35747809 | PubTator, text mining | PubMed |
| MicroRNA Regulation of Human Herpesvirus Latency. | Viruses | 2022 | 35746686 | PubTator, text mining | PubMed |
| Comprehensive Analysis and Experimental Validation of a Novel Estrogen/Progesterone-Related Prognostic Signature for Endometrial Cancer. | J Pers Med | 2022 | 35743699 | PubTator, text mining | PubMed |
Human Plasma Transcriptome Implicates Dysregulated S100A12 Expression: A Strong, Early-Stage Prognostic Factor in ST-Segment Elevated Myocardial Infarction: Bioinformatics Analysis and Experimental Verification. | Front Cardiovasc Med | 2022 | 35722095 | PubTator, text mining | PubMed |
| Underexpression of LINC00173 in TCF3/PBX1-Positive Cases Is Associated With Poor Prognosis in Children With B-Cell Precursor Acute Lymphoblastic Leukemia. | Front Oncol | 2022 | 35719952 | PubTator, text mining | PubMed |
| A Germline Mutation in ATR Is Associated With Lung Adenocarcinoma in Asian Patients. | Front Oncol | 2022 | 35712480 | PubTator, text mining | PubMed |
| ADAR1 Prevents R-loop Accumulation-Driven ATR Pathway Activation in Ovarian Cancer. | J Cancer | 2022 | 35711824 | PubTator, text mining | PubMed |
| Comprehensive analysis of KCTD family genes associated with hypoxic microenvironment and immune infiltration in lung adenocarcinoma. | Sci Rep | 2022 | 35705627 | PubTator, text mining | PubMed |
| Quantitative phosphoproteomics reveal cellular responses from caffeine, coumarin and quercetin in treated HepG2 cells. | Toxicol Appl Pharmacol | 2022 | 35688186 | PubTator, text mining | PubMed |
| Small molecule targeting FOXM1 DNA binding domain exhibits anti-tumor activity in ovarian cancer. | Cell Death Discov | 2022 | 35680842 | PubTator, text mining | PubMed |
| PROTACs: past, present and future. | Chem Soc Rev | 2022 | 35671157 | PubTator, text mining | PubMed |
| High abundance of CDC45 inhibits cell proliferation through elevation of HSPA6. | Cell Prolif | 2022 | 35642733 | PubTator, text mining | PubMed |
| METTL3 promotes cell cycle progression via m6A/YTHDF1-dependent regulation of CDC25B translation. | Int J Biol Sci | 2022 | 35637959 | PubTator, text mining | PubMed |
| Genome-Wide Gene Expression Profiling Defines the Mechanism of Anticancer Effect of Colorectal Cancer Cell-Derived Conditioned Medium on Acute Myeloid Leukemia. | Genes (Basel) | 2022 | 35627268 | PubTator, text mining | PubMed |
| Kinases on Double Duty: A Review of UniProtKB Annotated Bifunctionality within the Kinome. | Biomolecules | 2022 | 35625613 | PubTator, text mining | PubMed |
| SOCS7/HuR/FOXM1 signaling axis inhibited high-grade serous ovarian carcinoma progression. | J Exp Clin Cancer Res | 2022 | 35624501 | PubTator, text mining | PubMed |
| CDC25C is a prognostic biomarker and correlated with mitochondrial homeostasis in pancreatic adenocarcinoma. | Bioengineered | 2022 | 35615982 | PubTator, text mining | PubMed |
| CDC25C as a Predictive Biomarker for Immune Checkpoint Inhibitors in Patients With Lung Adenocarcinoma. | Front Oncol | 2022 | 35574406 | PubTator, text mining | PubMed |
| SEMA6D Differentially Regulates Proliferation, Migration, and Invasion of Breast Cell Lines. | ACS Omega | 2022 | 35571788 | PubTator, text mining | PubMed |
| A Computational Approach to Justifying Stratifin as a Candidate Diagnostic and Prognostic Biomarker for Pancreatic Cancer. | Biomed Res Int | 2022 | 35547358 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/994/papers?page=15